Skip navigation

Dr Simon Bridge

Senior Lecturer

Department: Applied Sciences

Simon Bridge Staffprofile Northumbriauniversity255

Simon is a viral immunologist who has worked in the field of virology and immunology since 1999 and gained considerable experience in academia, industry and the National Health Service. He trained in Immunology & Virology at Bristol University, Liverpool University, and the Liverpool School of Tropical Medicine. His PhD studies were supervised by Dr Tom Blanchard, the primary aim of his research work was to devise heterologous prime-boost-boost vaccines that would provide protection against HIV-1 by eliciting high titres of broadly reactive neutralising antibodies (Bridge et al., 2011a).

Simon returned to Newcastle University in 2006 for his postdoctoral research and worked in the laboratory of Professors Geoffrey Toms and Margaret Bassendine, and Dr Dermot Neely. His research focused on the association of hepatitis C virus (HCV) with very- and low-density lipoproteins (VLDL/LDL) in the blood of infected patient’s and to examine the metabolic factors, which influence this (Felmlee et al., 2010; Bridge et al., 2011b; Sheridan et al., 2012; Sheridan et al., 2014a, Bridge et al., 2015). This work culminated in a clinical trial investigating whether statins and n3 fatty acids reduced viral loads and the quantity of virus associated with LDL (Sheridan et al., 2014b).

In September 2015, Simon was appointed as a Senior Lecturer in Virology and Viral Immunology following a 3 year, Anniversary Research Fellow in the Faculty of Health & Life Sciences at Northumbria University. Simon maintains an active research interest in viral hepatitis and is particularly interested in the role of HCV in triggering atherosclerosis (Bridge et al., 2018). He is also interested in the role of the microbial communities in cardiovascular & pulmonary disease, inflammatory bowel disease and autoimmune liver disease.

Campus Address

Ellison building


Medicine PhD September 01 2003

Key Publications

  • Please visit the Pure Research Information Portal for further information
  • Covid‐19 and co‐morbidities, Bassendine, M., Bridge, S., McCaughan, G., Gorrell, M. 1 Sep 2020, In: Journal of Diabetes
  • Relapse of polymyalgia rheumatica following adjuvanted influenza vaccine, Bassendine, M., Bridge, S. 14 Jan 2020, In: European Journal of Rheumatology
  • SAT-221-Autoantibodies to apolipoprotein A1 (apoA-1), Pagano, S., Sheridan, D., Bridge, S., Shawa, I., Cramp, M., Taylor-Robinson, S., Neely, R., Vuilleumier, N., Bassendine, M. Apr 2019
  • Temperate bacteriophages from chronic Pseudomonas aeruginosa lung infections show disease-specific changes in host range and modulate antimicrobial susceptibility, Tariq, M., Everest, F., Cowley, L., Wright, R., Holt, G., Ingram, H., Duignan, L., Nelson, A., Lanyon, C., Perry, A., Perry, J., Bourke, S., Brockhurst, M., Bridge, S., de Soyza, A., Smith, D. 27 Aug 2019, In: mSystems
  • Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?, Bridge, S., Pagano, S., Jones, M., Foster, G., Neely, D., Vuilleumier, N., Bassendine, M. 8 Feb 2018, In: Hepatology International
  • Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?, Bridge, S., Pagano, S., Jones, M., Foster, G., Neely, R., Vuilleumier, N., Bassendine, M. Apr 2018
  • Shigatoxin encoding Bacteriophage φ24B modulates bacterial metabolism to raise antimicrobial tolerance, Holt, G., Lodge, J., McCarthy, A., Graham, A., Young, G., Bridge, S., Brown, A., Veses-Garcia, M., Lanyon, C., Sails, A., Allison, H., Smith, D. 1 Mar 2017, In: Scientific Reports
  • Hepatitis C virus and atherosclerosis: A legacy after virologic cure?, Bassendine, M., Nielsen, S., Bridge, S., Felmlee, D., Sheridan, D., Packard, C., Neely, R. 11 Nov 2016, In: Clinics and Research in Hepatology and Gastroenterology
  • A metagenomic approach to characterize temperate bacteriophage populations from Cystic Fibrosis and non-Cystic Fibrosis bronchiectasis patients, Tariq, M., Everest, F., Cowley, L., de Soyza, A., Holt, G., Bridge, S., Perry, A., Perry, J., Bourke, S., Cummings, S., Lanyon, C., Barr, J., Smith, D. 18 Feb 2015, In: Frontiers in Microbiology
  • P0725 : Lipidomics analysis of fasting serum identifies novel lipid biomarkers specific for HCV genotype 3 and genotype 1 chronic hepatitis C virus infection, Sheridan, D., Gomez Romero, M., Bridge, S., Crossey, M., Shawa, I., Neely, R., Felmlee, D., Holmes, E., Bassendine, M., Taylor-Robinson, S. 1 Apr 2015, In: Journal of Hepatology

a sign in front of a crowd

Northumbria Open Days

Open Days are a great way for you to get a feel of the University, the city of Newcastle upon Tyne and the course(s) you are interested in.

Research at Northumbria

Research at Northumbria

Research is the life blood of a University and at Northumbria University we pride ourselves on research that makes a difference; research that has application and affects people's lives.

a person sitting at a table

Order your prospectus

If you would like to know more about our courses, or life in general as a student at Northumbria, then we can help you.

Latest News and Features

From floods to Covid-19

Masters students from Northumbria University, Newcastle, are helping businesses in Cumbria…

More news

Back to top